Statera Biopharma Inc (STAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,059 | 1,126 | 1,487 | 2,238 | 2,799 |
| Marketable Securities | 360 | 452 | 427 | 396 | 541 |
| Receivables | 334 | 379 | 211 | 338 | 270 |
| Other current assets | 80 | 45 | 68 | 75 | 116 |
| TOTAL | $1,834 | $2,003 | $2,193 | $3,047 | $3,725 |
| Non-Current Assets | |||||
| PPE Net | 12 | 16 | 17 | 20 | 24 |
| Other Non-Current Assets | 19 | 19 | 19 | 19 | 31 |
| TOTAL | $31 | $34 | $36 | $39 | $55 |
| Total Assets | $1,865 | $2,037 | $2,229 | $3,086 | $3,780 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 266 | 264 | 100 | 275 | 245 |
| Accrued Expenses | 819 | 789 | 466 | 665 | 766 |
| TOTAL | $1,085 | $1,053 | $566 | $940 | $1,011 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 13 | -7 | 17 | 21 | 28 |
| TOTAL | $N/A | $N/A | $N/A | $4 | $7 |
| Total Liabilities | $1,085 | $1,053 | $566 | $943 | $1,018 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,403 | 11,403 | 11,298 | 11,298 | 11,298 |
| Common Shares | 57 | 57 | 57 | 57 | 57 |
| Retained earnings | -167,294 | -166,706 | -165,998 | -165,548 | -164,932 |
| Other shareholders' equity | 4,351 | 4,472 | 4,443 | 4,473 | 4,475 |
| TOTAL | $779 | $984 | $1,663 | $2,143 | $2,762 |
| Total Liabilities And Equity | $1,865 | $2,037 | $2,229 | $3,086 | $3,780 |